<--- Back to Details
First PageDocument Content
Bevacizumab / Brain tumor / Glioblastoma multiforme / University of Texas MD Anderson Cancer Center / Management of cancer / Colorectal cancer / Daniel Von Hoff / Prostate cancer / Medicine / Oncology / Cancer organizations
Date: 2014-05-31 07:25:26
Bevacizumab
Brain tumor
Glioblastoma multiforme
University of Texas MD Anderson Cancer Center
Management of cancer
Colorectal cancer
Daniel Von Hoff
Prostate cancer
Medicine
Oncology
Cancer organizations

Fall 2013 VOL 28 ISSUE 1 CONQUEST LOOKING

Add to Reading List

Source URL: www.mdanderson.org

Download Document from Source Website

File Size: 4,62 MB

Share Document on Facebook

Similar Documents

Uncertainty evaluation of image-based tumour control probability models in radiotherapy of prostate cancer using a visual analytic tool

DocID: 1vnrm - View Document

Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric

DocID: 1vi4a - View Document

Spring 2014 Issue YES TO LIFE YOUR OPTIONS FOR CANCER Dear Friends and Supporters, In the last Newsletter, we told you about our autumn London Seminar on prostate cancer, the first of our

DocID: 1v4PI - View Document

CANINE BLADDER CANCER by Deborah W. Knapp, DVM, Dipl. ACVIM Cancer of the urinary tract in dogs can affect the kidneys, ureters, urinary bladder, prostate, or urethra (see Figure 1). Within the urinary

DocID: 1uUAX - View Document

EDITORIAL Prostate cancer and selective serotonin reuptake inhibitors Alka Aggarwal Aggarwal A. Prostate cancer and selective serotonin reuptake inhibitors.Ann Histol Surg Pathol. 2017;1(1)5.

DocID: 1uKru - View Document